Norwood Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Norwood Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$19K	Hold	200	–	–	0.03%	210
2023 Q4	$17.9K	Hold	200	–	–	0.03%	195
2023 Q3	$14.6K	Sell	200 -50	-20%	-$3.99K	0.02%	205
2023 Q2	$20.8K	Hold	250	–	–	0.03%	189
2023 Q1	$19.1K	Hold	250	–	–	0.03%	183
2022 Q4	$20.8K	Hold	250	–	–	0.03%	178
2022 Q3	$20K	Sell	250 -75	-23%	-$6.32K	0.04%	182
2022 Q2	$24K	Buy	325 +50	+18%	+$3.75K	0.04%	172
2022 Q1	$25K	Buy	275 +205	+293%	+$18.9K	0.04%	175
2021 Q4	$8K	Buy	+70	New	+$8.44K	0.01%	226

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Norwood Financial's XBI Position: Q1 2024 in Review

Norwood Financial held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2024 at 200 shares worth $19K. The position accounts for 0.03% of the portfolio, ranked #210.

Norwood Financial first reported a position in XBI in Q4 2021 and has held it in 10 quarters since. The position peaked at $25K in Q1 2022. 780 funds tracked by Wall St. Rank hold XBI as of Q1 2024.

Norwood Financial held 200 shares of State Street SPDR S&P Biotech ETF worth $19K as of Q1 2024.
Norwood Financial left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2024.
State Street SPDR S&P Biotech ETF made up 0.03% of Norwood Financial's portfolio in Q1 2024, its #210 holding.
Norwood Financial first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 10 quarters since.
Norwood Financial's State Street SPDR S&P Biotech ETF position peaked at $25K in Q1 2022.
780 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.

Based on Norwood Financial's 13F filing for Q1 2024, filed 16 Apr 2024.